• English
    • français
  • Help
  •  | 
  • Contact
  •  | 
  • About
  •  | 
  • Login
  • HAL portal
  •  | 
  • Pages Pro
  • EN
  •  / 
  • FR
View Item 
  •   LillOA Home
  • Liste des unités
  • Cancer Heterogeneity, Plasticity and Resistance to Therapies (CANTHER) - UMR 9020 - UMR 1277
  • View Item
  •   LillOA Home
  • Liste des unités
  • Cancer Heterogeneity, Plasticity and Resistance to Therapies (CANTHER) - UMR 9020 - UMR 1277
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Molecular and cellular determinants in ...
  • BibTeX
  • CSV
  • Excel
  • RIS

Document type :
Communication dans un congrès avec actes
Title :
Molecular and cellular determinants in Chronic Kidney Disease
Author(s) :
Larrue, Romain [Auteur]
Hétérogénéité, Plasticité et Résistance aux Thérapies des Cancers = Cancer Heterogeneity, Plasticity and Resistance to Therapies - UMR 9020 - U 1277 [CANTHER]
Sousa, Corentin De [Auteur]
Hétérogénéité, Plasticité et Résistance aux Thérapies des Cancers = Cancer Heterogeneity, Plasticity and Resistance to Therapies - UMR 9020 - U 1277 [CANTHER]
Fellah, Sandy [Auteur]
Hétérogénéité, Plasticité et Résistance aux Thérapies des Cancers = Cancer Heterogeneity, Plasticity and Resistance to Therapies - UMR 9020 - U 1277 [CANTHER]
Glowacki, François [Auteur]
Hétérogénéité, Plasticité et Résistance aux Thérapies des Cancers = Cancer Heterogeneity, Plasticity and Resistance to Therapies - UMR 9020 - U 1277 [CANTHER]
Hauwaert, Cynthia van Der [Auteur]
Hétérogénéité, Plasticité et Résistance aux Thérapies des Cancers = Cancer Heterogeneity, Plasticity and Resistance to Therapies - UMR 9020 - U 1277 [CANTHER]
Cauffiez, Christelle [Auteur]
Hétérogénéité, Plasticité et Résistance aux Thérapies des Cancers = Cancer Heterogeneity, Plasticity and Resistance to Therapies - UMR 9020 - U 1277 [CANTHER]
Pottier, Nicolas [Auteur] refId
Hétérogénéité, Plasticité et Résistance aux Thérapies des Cancers = Cancer Heterogeneity, Plasticity and Resistance to Therapies - UMR 9020 - U 1277 [CANTHER]
Conference title :
Canther PhD Students’ Day
City :
Lille
Country :
France
Start date of the conference :
2021
HAL domain(s) :
Sciences du Vivant [q-bio]
English abstract : [en]
Introduction: Chronic kidney disease (CKD), defined as a diminished glomerular filtration rate or presence of impaired renal function markers for at least 3 months, is associated with a high risk to develop chronic end ...
Show more >
Introduction: Chronic kidney disease (CKD), defined as a diminished glomerular filtration rate or presence of impaired renal function markers for at least 3 months, is associated with a high risk to develop chronic end stage kidney failure which still have limited therapeutic options like dialysis or kidney transplantation. This thesis aims to identify new molecular and cellular markers linked with CKD and its complications including fibrosis.Methods: Next generation sequencing will be applied to identify genetic factors associated with hereditary nephropathies such as nephronophthisis (NPHP).Results: We demonstrate the utility of whole-genome sequencing (WGS) for the molecular diagnosis of NPHP by identifying two putative disease-causing intronic mutations in the NPHP3 gene, including one deep intronic variant. We further show that both intronic variants, by affecting splicing, result in a truncated nephrocystin-3 protein.Conclusion: This study provides a framework for applying WGS as a first-line diagnostic tool for highly heterogeneous disease such as NPHP and further suggests that deep intronic variations are an important underestimated cause of monogenic disorders.Show less >
Language :
Anglais
Peer reviewed article :
Oui
Audience :
Internationale
Popular science :
Non
Collections :
  • Cancer Heterogeneity, Plasticity and Resistance to Therapies (CANTHER) - UMR 9020 - UMR 1277
Source :
Harvested from HAL
Université de Lille

Mentions légales
Accessibilité : non conforme
Université de Lille © 2017